Announce Date | 02/25/2025 |
EPS Normalized Actual | $0.14 (Beat by $0.10987) |
EPS GAAP Actual | $0.14 (Beat by $0.10987) |
Revenue Actual | $1.08673B |
Revenue Surprise | Beat by $1086.73M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0 |
EPS GAAP Estimate | $0 |
Revenue Estimate | $0.7979417B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 3.42029 | 2.98 | 2.97493 | 3.768 | 1 |
Dec 2026 | 2.17162 | 4.69 | 2.08909 | 2.25413 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.2 | -0.2 | 1.08673B | 26.89% | 276.74M |
FQ1 2025 (Mar 2025) | -0.058 | -0.058 | 0.833533B | 7.22% | 0M |
FQ4 2024 (Dec 2024) | -0.2 | -0.39835 | 1.14852B | 6.6% | 1009.24M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 0.677016B | -6.07% | -1254.75M |
FQ2 2024 (Jun 2024) | -0.77 | -2.11259 | 0.794521B | -8.06% | -922.6M |
FQ1 2019 (Mar 2019) | -0.9 | -0.9 | 0.564351B | 100% | 564.35M |
FQ2 2019 (Jun 2019) | -0.9 | -0.9 | 0.564351B | 100% | 564.35M |
FQ3 2019 (Sep 2019) | -1.51 | -1.51 | 0.760229B | 100% | 760.23M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.7979417B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0 | -- | 0 | 0 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0.8B | 15.15 | 0.8B | 0.8B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
2
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -0.2 | -0.2 | 100% |
FQ1 2025 (Mar 2025) | 0 | -0.058 | -0.058 | 100% |
FQ4 2024 (Dec 2024) | 0.19835 | -0.2 | -0.39835 | 199.18% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 1.34259 | -0.77 | -2.11259 | 274.36% |
FQ1 2019 (Mar 2019) | -0.9 | -0.9 | 100% | |
FQ2 2019 (Jun 2019) | -0.9 | -0.9 | 100% | |
FQ3 2019 (Sep 2019) | -1.51 | -1.51 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.81B | $1.09B | $276.74M | 25.47% |
FQ1 2025 (Mar 2025) | $0.83B | $0.83B | $0M | 0% |
FQ4 2024 (Dec 2024) | $0.14B | $1.15B | $1009.24M | 87.87% |
FQ3 2024 (Sep 2024) | $1.93B | $0.68B | $-1254.75M | -185.34% |
FQ2 2024 (Jun 2024) | $1.72B | $0.79B | $-922.6M | -116.12% |
FQ1 2019 (Mar 2019) | $0B | $0.56B | $564.35M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0.56B | $564.35M | 100% |
FQ3 2019 (Sep 2019) | $0B | $0.76B | $760.23M | 100% |